Coffee in Health and Disease Prevention
Academic Press Inc (Verlag)
978-0-443-13868-3 (ISBN)
- Noch nicht erschienen (ca. Dezember 2024)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books. Vinood B. Patel, BSc, PhD, FRSC, is currently Professor in Clinical Biochemistry at the University of Westminster. In 2014 Dr Patel was elected as a Fellow to The Royal Society of Chemistry. Dr Patel graduated from the University of Portsmouth with a degree in Pharmacology and completed his PhD in protein metabolism from King’s College London in 1997. His postdoctoral work was carried out at Wake Forest University Baptist Medical School, NC, USA studying structural-functional alterations to mitochondrial ribosomes, where he developed novel techniques to characterize their biophysical properties. Research is being undertaken to study the role of nutrients, antioxidants, phytochemicals, iron, alcohol and fatty acids in the pathophysiology of liver disease. Other areas of interest are identifying new biomarkers that can be used for the diagnosis and prognosis of disease and understanding mitochondrial oxidative stress in neurological disorders and iron dysregulation in diabetes. Dr Patel is a nationally and internationally recognized researcher and has several edited biomedical books related to the use or investigation of active agents or components. These books include The Handbook of Nutrition, Diet, and Epigenetics, Branched Chain Amino Acids in Clinical Nutrition, Cancer: Oxidative Stress and Dietary Antioxidants, Toxicology: Oxidative Stress and Dietary Antioxidants, Molecular Nutrition: Vitamins, The Neuroscience of Pain, Cognitive Behavioural Therapy. He is Editor of the ten-volume series Biomarkers in Disease: Methods, Discoveries and Applications.
Section 1: Coffee, Coffee Drinking and Varieties
1. The coffee plant
2. Genotypes and chemical quality traits of coffee
3. Metabolomics as applied to analysis of coffee plants
4. Coffea arabica (Arabica)
5. Coffea canephora (Robusta)
6. Green coffee
7. Turkish Coffee
8. The genetics of the coffee plant
9. Coffee usage and cardiovascular effects and risk factors
10. Coffee drinking and metabolic syndrome
11. Genetic differences in coffee intakes
Section 2: Production and Processing
12. Single-serve capsule brews of coffee
13. Waste management of coffee residues
Section 3: Compositional and Nutritional Aspects
14. Coffee and its compounds: perceived bitterness intensities
15. The influence of coffee consumption and body composition
16. Effects of coffee in obesity: arterial stiffness
17. The contributing of coffee to total dietary caffeine intake
18. Espresso coffee and impact on blood cholesterol
19. Coffee composition: Ent-kaurane-type diterpene diastereomers
20. 2-phenylphenol in roasted coffee
21. COVID19 lockdown and coffee-derived caffeine intake
22. Serum biomarkers of coffee consumption
Section 4: General Aspects Of The Effects Of Coffee
23. Overview of health effects of coffee
24. Coffee and cardiovascular risk: a narrative
25. Coffee and effects on blood pressure
26. Plasma lipids, lipid metabolism and coffee
27. Coffee consumption and non-alcoholic fatty liver disease; a narrative
28. Coffee and its metabolites in relation to lung function
29. Coffee and diabetes
30. Coffee intake and asthma
31. Green coffee and the immune system
32. Coffee and effects on platelets
33. Coffee and the gut microbiome
34. Coffee intake and muscular performance
35. Coffee and exercise on blood biochemistry
36. Favourable effect of coffee on metabolic disease risk
37. Coffee?components and genomics in relation to cancer
38. Metabolomic signatures of long-term?coffee?consumption
39. Health effects of caffeinated vs. decaffeinated coffee
40. Human genetics and coffee: Functional single-nucleotide polymorphism and response to coffee consumption
Section 5: Focused Areas, Specific Coffee Components and Effects on Tissue and Organ Systems
41. Cafestol in coffee and cellular effects
42. Caffeic acid and use in cancer pathways
43. Caffeic acid in coffee and neurological effects
44. Caffeine and coffee craving
45. Caffeine and mental health symptoms
46. Caffeine usage in Alzheimer's disease: a new narrative
47. Caffeoylquinic acid and effects on macrophages
48. Caffeoylquinic acid in coffee types and their effects
49. Chlorogenic acid and cellular energy metabolism
50. Chlorogenic?acid and effects on blood pressure
51. Chlorogenic acid and usage in diabetic and prediabetic states
52. Kahweol and hepatotoxicity protection
53. Kahweol from coffee and peripheral antinociception
54. Trigonelline as a bioactive alkaloid in coffee: preventing kidney stones
55. Trigonelline in coffee and its effects
Section 6: Behavior and Brain
56. Espresso coffee and breakfast: impact on mood and cognition
57. Seizures in epilepsy and coffee consumption
58. Linking coffee, olfaction and use of grounds for assessing cognitive function
59. Blood-brain barrier and caffeine
60. Coffee consumption: links with anxiety and depression
61. Coffee and intake and dementia
Section 7: Adverse Effects of Coffee and Coffee-Related Products
62. Acrylamide in coffee
63. Toxic metals in coffee
64. Coffee and adverse birth outcomes
65. Coffee consumption in relation to sudden cardiac death
66. Adverse cardiovascular effects of coffee: tachycardia and beyond
Section 8: Comparison of Coffee and Tea in Health and Disease
67. Comparing coffee and tea with reference to multiple sclerosis
68. Comparing coffee and tea with reference to DNA methylation
69. Comparing coffee and tea with reference to clonidine-induced hypothermia
70. Comparing coffee and tea with reference to prostate cancer
71. Coffee and tea consumption and pregnancy
72. Comparing coffee and tea with reference to breast cancer
Section 9: Resources and Selective Methods
73. Methods for determining either Arabica and Robusta coffee
74. Isolation of diterpenes in coffee
75. NMR methods for profiling coffee
76. Methods for in silico studies on coffee and its extracts
77. Coffee and accelerator-based methods for its profiling
78. Genetic methods to evaluate evidence for causal effect of coffee on health
79. Resources
| Erscheint lt. Verlag | 1.12.2024 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 216 x 276 mm |
| Themenwelt | Technik ► Lebensmitteltechnologie |
| ISBN-10 | 0-443-13868-0 / 0443138680 |
| ISBN-13 | 978-0-443-13868-3 / 9780443138683 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
